At Axcellant, our Pharmacovigilance and Product Safety services ensure the highest level of patient safety and regulatory compliance throughout the clinical research process. By integrating proactive adverse event monitoring with robust risk management strategies, we safeguard public health and support informed decision-making in every trial.

At Axcellant, pharmacovigilance means a comprehensive approach to safety in clinical trials. We focus on patient safety by continuously monitoring adverse events and implementing effective drug risk management practices. Our commitment is to ensure that every aspect of safety—from clinical data review to risk evaluation—contributes to a secure and reliable research environment.
Our process is designed to deliver reliable safety monitoring and actionable insights:
Axcellant offers a comprehensive suite of pharmacovigilance services, including:
Partner with Axcellant to ensure comprehensive safety monitoring and robust risk management in your clinical trials. Our pharmacovigilance expertise, combined with dedicated regulatory support, empowers you to advance your research with confidence. Reach out today to learn more about our tailored services.
Our regulatory team specializes in crafting effective regulatory strategies and ensuring compliance throughout the project lifecycle. From initial planning to completion, we provide expert guidance to navigate complex regulatory frameworks with precision and efficiency.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant